On February 7, 2019, at the Exchange Conference UIC (Universitat Internacional de Catalunya) and the ACE Foundation, which took place in the Campus Salut of the UIC, our Clinical Research Unit (UDIC) presented its project to carry out clinical trials in a network system, involving different health centers for the performance of neurological clinical trials….
Our clinical trials unit will start a new phase I trial in patients with early Parkinson’s disease. Patients will be included in different cohorts, single dose and ascending doses, in patients with or without mutations in the LRRK2 gene, by means of an intrathecal administration of an antisense oligonucleotide. Only 62 patients will participate in…
Our clinical trials unit has participated in the development of the AMBAR study, carried out at the General University Hospital of Catalonia and the ACE Foundation. It aims to reduce cerebral amyloid and improve cognitive performance, through plasmapheresis and the plasmatic replacement of albumin and / or immunoglobulins. This phase II/III trial has shown positive…
– Sant Cugat del Vallés 12/04/2018. The UDIC has been awarded the prize for the best team of those participating in the Mission trial. This study, developed at the General University Hospital of Catalonia, evaluates the efficacy and safety of an oral anti-amyloid medication in mild Alzheimer’s disease. It is awarded by the company Syneos…